In October 2023, we announced our acquisition by Aileron Therapeutics. For more information on the change, click here:?
Lung Therapeutics
生物技术研究
Austin，TX 1,914 位关注者
Lung Therapeutics is developing first-in-class medicines for unmet medical needs in fibrosis and lung disease.
关于我们
In October, 2023 Lung Therapeutics was acquired by Aileron Therapeutics. Aileron is now a pharmaceutical company targeting niche, orphan drug indications for lung injury and disease, with an emphasis on fibrosis. The company is developing a proprietary pipeline of therapeutics with the potential to greatly improve outcomes over currently available treatments. The company’s lead clinical programs include LTI-03 for idiopathic pulmonary fibrosis (IPF) and LTI-01 for loculated pleural effusion (LPE). For more information about the company, please visit https://aileronrx.com
- 网站
-
https://aileronrx.com
Lung Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Austin，TX
- 类型
- 上市公司
- 创立
- 2013
地点
-
主要
获取路线
3801 S Capitol of Tx Hwy
Ste 330
US，TX，Austin，78704